Skip to main content
Equibles

HYL · Hyloris Pharmaceuticals · Financials

Use HYL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HYL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
4.0000 EUR +0.0900 (+2.30%) At close · Oct 7
Rebalance outlook locked
Market Cap
124.60M EUR
Shares
28.00M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
7.21M -14.8%
FY2025 Revenue FY2020–FY2025
Net Income
-6.33M +0.1%
FY2025 Net Income FY2020–FY2025
Gross Margin
317.44% +220.9pp
FY2022 Gross Margin FY2020–FY2022
Operating Margin
-94.46% -10.2pp
FY2025 Operating Margin FY2020–FY2025
Operating Cash Flow
-6.99M +2.8%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
EUR 7.21M 8.46M 2.09M 900K 3.1M 175K
EUR 379K 227K 93K 94K 107K 145K
EUR — — — 2.86M 2.99M 30K
EUR 11.28M 10.27M 14.42M 10.27M 5.06M 3.41M
EUR 4.88M 5.63M 5.55M 3.52M 2.9M 2.19M
EUR -6.81M -7.13M -15.99M -11.64M -10.54M -7.03M
EUR 739K 378K 285K 730K 773K 1.02M
EUR -6.71M -6.34M -15.38M -11.9M -11.28M -7.15M
EUR -374K 0 0 4000 297K 1000
EUR -6.33M -6.34M -15.38M -11.91M -11.58M -7.15M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent long-term borrowings 2025-12-31 EUR 1,246,000 ESEF Annual Report filed 2026-05-12
Short-term borrowings 2025-12-31 EUR 364,000 ESEF Annual Report filed 2026-05-12
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.